Lyra Therapeutics, Inc.LYRANASDAQ
Loading
Current Ratio Over TimeCompressed
Percentile Rank33
3Y CAGR+9.1%
5Y CAGR+11.9%
Year-over-Year Change
Current ratio (current assets / current liabilities)
3Y CAGR
+9.1%/yr
Annual compound
5Y CAGR
+11.9%/yr
Consistent
Percentile
P33
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 3.41 | -36.3% |
| 2023 | 5.35 | -23.2% |
| 2022 | 6.97 | +165.3% |
| 2021 | 2.63 | -83.1% |
| 2020 | 15.54 | +700.0% |
| 2019 | 1.94 | -84.7% |
| 2018 | 12.72 | - |